DS-5565 Phase III Study for Renal Impairment in Japanese Subjects
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Investigate the safety and efficacy of DS-5565 in Japanese subjects with Diabetic Peripheral
Neuropathic Pain (DPNP) with renal impairment or Post-Herpetic Neuralgia (PHN) with renal
impairment.